AOD-9604 is a 16-residue C-terminal fragment of human growth hormone engineered to isolate lipolytic activity without engaging the full hGH receptor cascade.
AOD-9604 corresponds to the 176–191 region of human growth hormone with an added N-terminal tyrosine to aid solubility and analytical detection. Published research isolates lipolytic effects on adipocytes without activation of the classical hGH receptor pathway.
Structural identity
- 17 residues total (Tyr + hGH176-191).
- Average mass ~1815 Da.
- Intramolecular disulfide bridge between Cys residues.
Mechanism (research literature)
Published in-vitro literature describes β3-adrenergic-like signalling in adipocyte cultures, elevated lipolysis and reduced lipogenesis without measurable IGF-1 induction.
- Batch identifier and synthesis date traceable to the lot record
- HPLC purity ≥98% (typically ≥99% for peptides under 30 residues)
- LC-MS confirmed monoisotopic or average mass within ±0.5 Da of theoretical
- Counterion identity and content (acetate or trifluoroacetate) reported
- Bacterial endotoxin and residual solvents per the analytical method
Research use only. All information on this page is provided strictly for in-vitro and laboratory research reference. Nothing in this article is medical, therapeutic, dosing, or performance advice for human or veterinary use.
